Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iniparib (BSI-201) (BSI-201) , a PARP1 inhibitor, exhibits potency in triple-negative breast Y (TNBC).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 46.00 | |
10 mg | In stock | $ 70.00 | |
25 mg | In stock | $ 128.00 | |
50 mg | In stock | $ 241.00 | |
100 mg | In stock | $ 378.00 | |
200 mg | In stock | $ 600.00 | |
500 mg | In stock | $ 959.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Iniparib (BSI-201) (BSI-201) , a PARP1 inhibitor, exhibits potency in triple-negative breast Y (TNBC). |
Cell Research | Cells are exposed to various concentrations of BSI-201 for 5, and 9 days in the presence or absence of buthionine sulfoxamide (BSO). After treatment, cell proliferation is measured by CellTiter-Glo assay.(Only for Reference) |
Synonyms | NSC-746045, IND-71677, BSI-201 |
Molecular Weight | 292.03 |
Formula | C7H5IN2O3 |
CAS No. | 160003-66-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 14.6 mg/mL (50 mM)
DMSO: 14.6 mg/mL (50 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Iniparib 160003-66-7 Chromatin/Epigenetic DNA Damage/DNA Repair Microbiology/Virology PARP Influenza Virus NSC-746045 Inhibitor BSI201 inhibit BSI 201 IND-71677 NSC 746045 IND 71677 NSC746045 IND71677 poly ADP ribose polymerase BSI-201 inhibitor